News

manilatimes5d
IASO Bio presents promising efficacy of Equecabtagene Autoleucel in patients with Multiple Sclerosis in IIT study at the 11th Congress of the European ... - The Manila Times
SHANGHAI and NANJING, China and SAN FRANCISCO, June 23, 2025 /PRNewswire/ -- IASO Biotherapeutics ('IASO Bio'), a biopharmaceutical company focused on the discovery, development, manufacturing, and ...
Medindia5d
IASO Bio presents promising efficacy of Equecabtagene Autoleucel in patients with Multiple Sclerosis in IIT study at the 11th Congress of the European Academy o - Medindia
Title: Anti-BCMA CAR T cell therapy in patients with Multiple Sclerosis Type: E-presentation Time: 14:00 – 14:05 (Eastern European Summer Time), June 22, 2025 ...
The Victoria Advocate6d
IASO Bio presents promising efficacy of Equecabtagene Autoleucel in patients with Multiple Sclerosis in IIT study at the 11th Congress of the European ... - Victoria Advocate
Time: 14:00 – 14:05 (Eastern European Summer Time), June 22, 2025 Location: Helsinki, Finland Abstract ID: A-25-13667 Presenter: Prof. Chuan Qin, Tongji Hospital, Tongji Medical College ...
NDTV20h
Latest and Breaking Hyderabad News - NDTV.com
Today’s Hyderabad News: Get all the Latest and Breaking Hyderabad News on NDTV. Live local Hyderabad news coverage and updates on Politics, elections, Weather, Crime, and More ...
Science Daily1d
ScienceDaily: Your source for the latest research news
Breaking science news and articles on global warming, extrasolar planets, stem cells, bird flu, autism, nanotechnology, dinosaurs, evolution -- the latest discoveries ...
Cardiff University1d
Find a postgraduate taught course - Study - Cardiff University
Choose from over 200 programmes which will allow you to study a subject in more depth and increase your career prospects by developing your transferable skills to a higher level. Refine. Mode of study ...